Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2023 | Percentile | Sector n |
|---|---|---|---|---|
| Floreal | Beauty & Personal Care | 22.5% | 79th pct | 39 |
| Maigrinvei Georgia | Beauty & Personal Care | 20.5% | 67th pct | 39 |
| Akademia | Beauty & Personal Care | 19.5% | 64th pct | 39 |
| Algeti | Beauty & Personal Care | 15.9% | 51st pct | 39 |
| Kalta Bedniereba | Beauty & Personal Care | 5.3% | 18th pct | 39 |
Percentile is within each company's own sector across the whole FY2023 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2023 | Floreal | Akademia | Maigrinvei Georgia | Kalta Bedniereba | Algeti |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 63.6% | 36.7% | 45.9% | 42.2% | 19.2% |
| EBITDA Margin | 22.5% | 19.5% | 20.5% | 5.3% | 15.9% |
| EBITDAR | 2,108 | 1,732 | 1,458 | 1,193 | 1,016 |
| EBITDAR Margin | 23.7% | 21.5% | 20.6% | 17.0% | 16.5% |
| EBIT Margin | 11.8% | 19.0% | 20.4% | 5.0% | 15.9% |
| Net Profit Margin | -8.7% | 12.3% | 27.9% | 4.5% | 15.9% |
| Operating Expense % of Sales | 41.1% | 17.2% | 25.5% | 36.9% | 3.3% |
| Returns | |||||
| Return on Assets (ROA) | -6.0% | 49.0% | 63.6% | 11.8% | 41.3% |
| Return on Equity (ROE) | -8.3% | 49.2% | 71.8% | 142.7% | 41.3% |
| ROIC [EBIT / Invested Capital] | 10.8% | 101.3% | 89.7% | 49.9% | 47.6% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 20.4% | 0.0% | 0.0% | 27.4% | 0.0% |
| Debt-to-Equity | 0.28x | 0.00x | 0.00x | 3.32x | 0.00x |
| Debt-to-EBITDA | 1.31x | 0.00x | 0.00x | 1.98x | 0.00x |
| Equity-to-Assets | 72.1% | 99.5% | 88.6% | 8.3% | 100.0% |
| Net Debt | 435 | -504 | -1,145 | 476 | -315 |
| Cash & Equivalents | 2,198 | 504 | 1,145 | 264 | 315 |
| Total Debt | 2,634 | N/A | N/A | 740 | N/A |
| Liquidity & working capital | |||||
| Current Ratio | 4.09x | 199.37x | 8.75x | 1.01x | N/A |
| Quick Ratio | 2.38x | 199.37x | 8.75x | 1.02x | N/A |
| Cash Ratio | 1.34x | 54.11x | 3.23x | 0.14x | N/A |
| Total Current Assets | 6,739 | 1,855 | 3,103 | 1,905 | 301 |
| Total Current Liabilities | 1,646 | 9 | 355 | 1,878 | N/A |
| Inventory | 2,824 | N/A | N/A | -3 | N/A |
| Trade Receivables | 3,380 | 111 | 82 | 23 | 301 |
| Trade Payables | 916 | 9 | 336 | 1,605 | N/A |
| Net Working Capital | 5,093 | 1,846 | 2,748 | 27 | 301 |
| Net Working Capital % of Revenue | 57.2% | 22.9% | 38.8% | 0.4% | 4.9% |
| Trade Working Capital | 5,288 | 101 | -254 | -1,585 | 301 |
| Trade Working Capital % of Revenue | 59.4% | 1.3% | -3.6% | -22.6% | 4.9% |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | 1.15x | N/A | N/A | -1290.02x | N/A |
| Days Inventory Outstanding (DIO) | 317.9 | N/A | N/A | -0.3 | N/A |
| Receivables Turnover | 2.63x | 72.82x | 86.19x | 304.40x | 20.48x |
| Days Sales Outstanding (DSO) | 138.6 | 5.0 | 4.2 | 1.2 | 17.8 |
| Payables Turnover | 3.54x | 548.17x | 11.41x | 2.52x | N/A |
| Days Payable Outstanding (DPO) | 103.1 | 0.7 | 32.0 | 144.7 | N/A |
| Cash Conversion Cycle | 353.3 days | 4.3 days | -27.8 days | -143.8 days | 17.8 days |
| Asset Turnover | 0.69x | 3.98x | 2.28x | 2.60x | 2.60x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 2,116 | 8,208 | N/A | 192 | 102 |
| Free Cash Flow (OCF − Capex proxy) | 1,884 | -16 | N/A | -512 | 102 |
| Cash Conversion (OCF / EBITDA) | 105.5% | 523.7% | N/A | 51.4% | 10.4% |
| Dividends Declared | 1,684 | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A |